SkinBit
Stub active Updated Aug 5, 2026This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.
About
SkinBit is an AI-driven skin-cancer screening company building a proprietary imaging hardware platform combined with a longitudinal dermatology data platform, aimed at making 20-minute full-body screenings widely available in clinics across the United States 1. The company’s model creates historical imaging records so physicians can make objective comparisons across visits rather than relying on visual examinations and patient recall 1. As of the funding announcement, SkinBit reported a waitlist exceeding 5,000 prospective users generated without paid marketing and was in discussions for more than 20 clinical locations 1.
Disclaimer: This is a lean profile built from initial round coverage and may be expanded as more information becomes available.
Funding History
| Date | Round | Amount | Lead | Co-investors |
|---|---|---|---|---|
| 2026-08-05 | Pre-Seed | $6M | Boost VC, Cleo Capital, Manna Ventures | Additional undisclosed participants 1 |
Proceeds will fund the launch of the first three clinical locations in 2026 and expansion to 15 sites by end of 2027 1.
What Investors Say
No independently sourced investor commentary beyond press-release attribution at this time.
What Founders Say
No independently sourced founder testimonials found at time of profile creation.